[Clinical analysis of autoimmune diseases associated with interstitial lung diseases initially presented with idiopathic pulmonary fibrosis].

医学 特发性肺纤维化 内科学 间质性肺病 肺纤维化 胃肠病学
作者
Rong Chen,X N Liu,C Shao,Houfeng Huang,K Hu,Jiaming Xu,Xian Li,Z J Zhang,Zuojun Xu
出处
期刊:PubMed 卷期号:45 (8): 775-782
标识
DOI:10.3760/cma.j.cn112147-20220417-00327
摘要

Objectives: To describe the clinical characteristics of patients with autoimmune diseases associated interstitial lung diseases (AID-ILD) initially presented with idiopathic pulmonary fibrosis (IPF) in a tertiary Chinese hospital. Methods: We conducted a retrospective analysis of 14 patients diagnosed with AID-ILD during the IPF follow-up between January 2016 and December 2021. Among the 14 enrolled AID-ILD cases, there were 13 males and 1 female, (69.71±9.07) years old (range from 55 y to 87 y). Results: Detailed clinical consultation and further laboratory analysis were performed during the follow-up when the IPF patients showed exaggerated dyspnea (7 cases), fever of unknown causes (6 cases), microscopic hematuria (5 cases), arthralgia and swelling (4 cases), arthralgia (2 cases), morning stiffness (2 cases) and renal failure (2 cases). Finally, 6 patients showed positive MPO-ANCA, one patient showed positive PR3-ANCA and 7 patients showed positive anti-CCP. During the IPF periods, 7 patients had received antifibrotic agents and 5 patients had been prescribed with N-acetylcysteine, and 1 patient had received antifibrotic agents after N-acetylcysteine. Among them, no medication was prescribed for one IPF patient. After they were diagnosed with AID-ILD, glucocorticoids and/or immunosuppressants were added for 13 of them. Thirteen of cases improved or stable after these treatments, but one didn't show significant changes. Conclusions: AID-UIP, especially ANCA-UIP, AAV-UIP or RA-UIP should be considered when the IPF patients showed fever of unknown origin, microscopic hematuria and/or arthritis related symptoms. They might benefit from the add-on glucocorticoids and/or immunosuppressants.目的: 总结以特发性肺纤维化(IPF)起病的自身免疫性疾病相关性间质性肺疾病(AID-ILD)患者的临床特征,提高临床医生对此类疾病的认识。 方法: 回顾性纳入2016年1月至2021年12月北京协和医院就诊的、以IPF起病的14例AID-ILD患者,分析其临床资料,其中男13例,女1例,年龄55~87(69.7±9.1)岁。总结诊疗过程以及疗效。 结果: 所有患者均在确诊IPF后规律随访,因出现以下临床表现进一步筛查发现AID:气短加重7例、发热6例,镜下血尿5例,关节肿痛4例,关节痛、晨僵、肾功能不全2例。最终诊断髓过氧化物酶抗体(MPO)-中性粒细胞胞质抗体(ANCA)阳性6例,抗蛋白酶3抗体(PR-3)-ANCA阳性1例,抗环瓜氨酸肽阳性7例。在最初诊断为IPF阶段,7例接受抗纤维化药物治疗,5例使用N-乙酰半胱氨酸,1例使用N-乙酰半胱氨酸后加用抗纤维化药物,1例患者未接受药物治疗。诊断AID-ILD后,1例继续吡非尼酮治疗,其余均加用了激素和(或)免疫抑制剂;调整治疗方案后,13例患者病情均好转或稳定。 结论: IPF患者出现发热、镜下血尿以及关节炎的相关表现时,需要警惕AID-ILD可能,尤其是ANCA相关性寻常型间质性肺炎(UIP)、ANCA相关性血管炎-UIP和类风湿关节炎相关性-UIP;加用激素和(或)免疫抑制剂治疗可能使其获益。.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
eric888应助辛勤的诗蕊采纳,获得50
1秒前
1秒前
顺利毕业完成签到,获得积分10
1秒前
2秒前
科研小白完成签到,获得积分10
2秒前
Ava应助甜蜜花采纳,获得10
2秒前
上官若男应助Raza采纳,获得10
2秒前
3秒前
Ava应助眼睛大行云采纳,获得10
3秒前
4秒前
xue完成签到 ,获得积分10
4秒前
健忘丹珍完成签到,获得积分10
4秒前
4秒前
4秒前
坤坤蹦蹦跳跳完成签到,获得积分10
6秒前
害羞映容完成签到,获得积分10
6秒前
科研通AI6应助小亮哈哈采纳,获得10
6秒前
6秒前
6秒前
所所应助liriyii采纳,获得10
6秒前
核糖体完成签到,获得积分20
7秒前
8秒前
Lloignyth完成签到,获得积分10
8秒前
赵苏程完成签到,获得积分10
8秒前
8秒前
8秒前
乐乐应助小张醒了采纳,获得10
9秒前
半凡完成签到,获得积分10
9秒前
小小666完成签到 ,获得积分10
9秒前
幽悠梦儿发布了新的文献求助10
10秒前
10秒前
10秒前
10秒前
Elin完成签到,获得积分10
10秒前
量子星尘发布了新的文献求助10
10秒前
平平无奇发布了新的文献求助10
11秒前
11秒前
青年才俊发布了新的文献求助10
11秒前
beijita完成签到,获得积分10
12秒前
星辰大海应助ZhangF采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Acute Mountain Sickness 2000
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
Thomas Hobbes' Mechanical Conception of Nature 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5097313
求助须知:如何正确求助?哪些是违规求助? 4309783
关于积分的说明 13428428
捐赠科研通 4137300
什么是DOI,文献DOI怎么找? 2266533
邀请新用户注册赠送积分活动 1269654
关于科研通互助平台的介绍 1205978